Batch-25 students of ACRI, gave a very informative, well researched and very good technical group discussion on the topic of ''TRANSLATIONAL RESEARCH".

A Systematic Review of Medical Research

*  Decide which studies to include in the review. The first and most important decision is to decide what research question will be answered. This is expressed as an aim, for example: 'To assess the effects of a new drug for a particular health problem in   certain types of people.'

 *  Decide which studies to include in the review. This will be decided in part by the tightly defined research question, but there are further 'eligibility criteria' that must be decided in advance for the inclusion or exclusion of studies. Typically, all the studies need to be of a rigorous design, such as a randomized controlled trial.

 *  Search for the studies. The sources consulted, and the search terms used to trawl them are outlined for attack - in the case of Cochrane reviews, by specially trained search coordinators. Attempts should also be made in the search to reveal unpublished studies.

 *  Select the studies and collect data from them. Data are extracted from the studies that meet the eligibility criteria set out in advance. The data relevant to the research question being investigated may have to be extracted from varied formats.

 *  Assess the risk of bias in the included studies. This is a process to ensure that all the studies reviewed are relevant and reliable. For example, was the randomization in the trial double-blinded? Or was there a risk of bias over which participants were selected for either treatment or comparison? Some studies may be of a lower quality, but they can still be included, so long as this assessment of bias is taken into account.

 *  Analyze the data and undertake meta-analyses. This is the core process of a systematic review, the main step towards synthesizing conclusions. Researchers are warned not to jump straight into this process of data analysis without first defining the aims and taking the precautions in the above steps.

 *  Address any publication bias. One of the disadvantages of systematic reviews is publication bias, which effectively means study results being cherry-picked. The risk is that a systematic review misrepresents the true effects of treatment, so this step is designed to address that concern.

 *  Present the final results of the review.

- including 'summary of findings' tables. This is the published outcome of the work used by healthcare decision-makers.

Kidney stones may increase the risk of heart disease, stroke

A kidney stone is an accumulation of waste chemicals in the kidney - calcium, oxalate, cystine, phosphate, xanthine and irate - that become a hard mass. Normally, these chemicals are passed out of the body through urine, but they can build up if there is not enough liquid to get rid of them.

Once these stones are formed, they either stay in the kidney or move down the urinary tract into the ureter. Smaller stones can be passed out the body in urine without causing major discomfort, but larger stones may become stuck. Urine can build up behind the stones, causing a lot of pain.

Study results found that patients with kidney stones are at 19% higher risk of coronary heart disease and 40% higher risk of stroke.

Commonly prescribed antibiotic 'could increase risk of cardiac death'

Clarithromycin belongs to a class of drugs known as macrolide antibiotics. It is used to treat an array of bacterial infections, including pneumonia, bronchitis and ear, sinus, skin and throat infections.

According to the research, macrolide antibiotics increase the duration of the heart muscle's electrical activity - known as the QT interval - which can lead to abnormal heart rhythm (arrhythmia), a known risk factor for stroke and sudden cardiac arrest.

Heart failure: transplantation of animal organs into human patients 'more viable'

Heart transplantation is the main treatment for end stage heart failure. Heart patients awaiting a transplant must rely on mechanical devices, which can increase the risk of infection, blood clots and bleeding in the patient.

A proposed alternative has been to use animal hearts in human patients, which is known as "xenotransplantation."

Scientists have reported success in transplanting the hearts from genetically engineered piglets into the abdomens of baboons, where the hearts have survived for more than 1 year. 

Firstly, pigs were genetically engineered to be a source of donor organs. These pigs had human genes that make their organs more compatible with human physiology. Pigs were chosen because their anatomy is similar to human anatomy.

Dear All,

Please find below the workshop brochure. If interested kindly mail us at smitha.p@acriindia.com. Post your confirmation, mode of payment would be communicated to you.

For any queries kindly contact - 08049203 714, 715, 09538872289.

                                                          

ACRI-Clinical Research Institute

#33, 3rd Flr, 15th Cross, 100ft Outer Ring Road,
2nd Phase J.P. Nagar, Bangalore – 560078

www.acriindia.com

WORKSHOP ON BASIC SAS

We are pleased to invite you to a one day workshop on one of the most significant topics – Basic SAS [Statistical Analytical Software] which would be conducted by ACRI in the first week of September, 2014.

SAS training would indeed provide a career with better growth potential and more options in terms of variety of jobs. There is a steady demand for SAS professionals throughout the pharmaceutical industry. It is crucial for Pharmaceutical companies, Biotechs and CRO’s to have SAS expertise from both statistical and data management point of view.

So come one, come all and get the best out of this valuable workshop. 

Kindly confirm your interest by calling 08049203714/715.